Education
About Us
Working with TipRanks
Follow Us
Said Darwazah Insider Profile
4 Followers
Said Darwazah, Chairman at Hikma Pharmaceuticals, holds 14.93M shares in Hikma Pharmaceuticals (Ticker: GB:HIK). Most recently, Said Darwazah Bought 530,000 shares of Hikma Pharmaceuticals on Nov 11, 2025 for an estimated value of 8.37M.
Profitable Transactions
3 out of 32 Profitable Transactions
Average Return
-24.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chairman
Roles that Said Darwazah holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 13, 2019 - Mar 13, 2020
Return:+28.00%
The most profitable trade made by Said Darwazah
Said Darwazah's Trading History
List of latest transactions for each holding click on a transaction to see Said Darwazah's performance on stock
You May Also Like
Said Darwazah insider profile FAQ
What is the percentage of profitable transactions made by Said Darwazah?
The percentage of profitable transactions made by Said Darwazah is 9%.
What is the average return per transaction made by Said Darwazah?
The average return per transaction made by Said Darwazah is -24.20%.
What stocks does Said Darwazah hold?
Said Darwazah holds: GB:HIK stocks.
What was Said Darwazah’s latest transaction?
Said Darwazah latest transaction was an Informative Buy of 8.37M.
What was Said Darwazah's most profitable transaction?
Said Darwazah’s most profitable transaction was an Informative Buy of GB:HIK stock on March 13, 2019. The return on the trade was 28.00%.
What is Said Darwazah's role in Hikma Pharmaceuticals?
Said Darwazah's role in Hikma Pharmaceuticals is Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.